Product information and disease descriptionProduct descriptionProduct information
Dosing and administration
9 evidence topics · 6 sources
BIM-IOL System
Open-angle glaucoma or ocular hypertension
- Manufacturer
- SpyGlass Pharma
- Regulatory submission
- NDA planned for 2028
- Launch
- Not announced
- Last updated